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Background: Diabetes is a chronic condition which requires many patients to use medications for the remainder
of their lives. While this regimen is demanding, little research has been done on the experiences individuals have
with diabetes medication use and the continuity of use, especially patients from rural areas of Tanzania. This study
explores the lived experiences of diabetes medication use and the continuity of use among adult diabetes patients
from rural communities with limited access to diabetes medicines.
Methods: We conducted 19 in-depth interviews to explore patients’ experiences with diabetes medication use and
the continuity of use. We employed the 5As of access to care to situate the behavioral practices surrounding
diabetes medication use in the study settings. The data analysis followed grounded theory principles, and was
conducted with the help of NVivo 9.
Results: Study participants expressed positive attitudes toward the use of diabetes medicines, but also concerns
about affordability. The patients employed two main strategies for dealing with the cost. The first was to increase
their available funds by spending less money on family needs, selling household property, asking family and friends
for money, or borrowing cash. They also reported sourcing medicines from pharmacies to save on consultation and
laboratory costs. Second, participants reported using less than the recommended dosage or skipping doses, and
sharing medicines. The geographic accessibility of diabetes service providers, the availability of medication, and the
organization of the diabetes services were also cited as barriers to taking medications and to using them
continuously.
Conclusions: The strategies employed by the people in this study illustrate their resilience in the face of poverty
and failing health care systems. More comprehensive strategies are therefore needed to encourage consistent
medication use among people with chronic conditions. These strategies could include the reduction of prices by
pharmaceuticals, the strengthening of community risk-pooling mechanisms and sustained health campaigns aimed
at patients and the community.
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Diabetes is a global pandemic, and increasingly affects the
people of sub-Saharan Africa (SSA) [1,2]. The increasing
prevalence of diabetes among other non-communicable dis-
eases (NCDs) is shaped by the demographic and the epi-
demiological transition, which is characterized by rapid
urbanization [2], the aging of the population, and changes in
behavioral and dietary practices associated with economic
development [1,3,4]. Type 2 is the most common type of
diabetes. It usually occurs in adults, but is increasingly ob-
served in children and adolescents as well [1]. More than
half of all diabetes cases in Africa are in Tanzania, South
Africa, Nigeria, and Ethiopia [1]. Tanzania alone had more
than 1.7 million people with diabetes in 2013. Type 2 dia-
betes is associated with overweight, and weight reduction
through diet or exercise or in combination with medication
can help to control the condition [5]. Many diabetes patients
have to take medication for the rest of their lives to improve
their insulin uptake and to prevent or delay the development
of complications and premature death [1]. For rural areas of
SSA, especially of Tanzania, information about the behav-
ioral experiences related to long-term medication use
among NCD patients has so far been limited.
The main challenge in managing diabetes in SSA is pro-
viding accessible care and appropriate medications to pa-
tients who need them [6]. The delivery of diabetes services
and the resources for managing the condition compete
with the need to combat infectious conditions such as
HIV/AIDS, tuberculosis, and malaria [2,6-8]. In response
to the scarcity of resources and the disease patterns, SSA
health systems have focused on providing episodic care
for acute symptomatic conditions [9,10] and services for
maternal, infant, and child health [7]. The episodic model
of care is not suited to managing NCDs, which involves
continuing care [11,12]. Many people with NCDs, includ-
ing diabetes, are unable to obtain continuous appropriate
care [6,8,13] due to problems related to quality and access
[3,6,8,14]. Lack of access to continuing diabetes care is as-
sociated with poor health outcomes and/or premature
death [15]. However, there is a lack of in-depth knowledge
about how people with diabetes in SSA manage their pre-
scribed medicines. This information can be used to better
plan and tailor interventions for facilitating continuity of
care for patients with chronic conditions.
In Tanzania, the establishment in 2003 of a network of
diabetes clinics markedly improved the access to and
provision of diabetes treatments and services. Before the
network was created, diabetes services were offered at re-
gional hospitals through outpatient care by general practi-
tioners, and at specialized referral hospitals [16]. Although
access to diabetes services has improved, these services
are mainly provided at the district, regional, and referral
hospitals levels (see Figure 1), and are thus primarily avail-
able in urban areas.According to a recent national survey, diabetes services
were available in 20% of urban and 9% of rural health
facilities, but only half of these facilities had the diagnostic
capabilities, the drugs, the medical personnel, and the
guidelines needed for diagnosis and patient management
on the day of the survey [17]. Systematic reviews of diabetes
medication use have reported that non-adherence [18-20]
is common. This paper explores how access to diabetes ser-
vices in rural areas shapes individuals’ behavior and their
experiences regarding medication use and continuity.
Access as a concept
The concept of access has been defined in different ways
[21-23]. This study will use the definition by Peters et al.
[23] “the timely use of service according to the need” [23].
Access to care becomes one of the major concerns when
time is an important factor in the utilization of health ser-
vices [24]. Penchnasky and Thomas 1981 defined five spe-
cific areas, referred to as the 5As of access, to indicate the
“degree of fit between the patient and the health care sys-
tem” [22]. The 5As of access to care (see Table 1) are
among the dimensions which influence the initiation and
utilization of health services when and where the services
are needed [23,24].
The literature has shown that the majority of diabetes pa-
tients in most resource-poor countries are dying because
they cannot access insulin [13,25,26]. The availability of dia-
betes medications [13,14,27] and their affordability [2,25,28]
are the main barriers to medication use and continuity
among diabetes patients. Lack of access to these treatments,
service disparities between urban and rural areas, high costs,
perceptions of symptoms, and satisfaction with the quality
of services provided are among the obstacles to diabetes
self-care, including to continuity of medication use [15,29].
Although the access to care dimensions are well-suited
to and have been widely used in assessing barriers to
health care service utilization in low-income countries
[23,24,30] and elsewhere [21,31], in this article we use
the dimensions to situate the behavioral practices sur-
rounding diabetes medication use and continuity in a
rural setting. Only a few existing studies have looked at
the medication use experiences of patients, especially of
those with non-communicable diseases such as diabetes.
The current study, which aims to fill this gap, is timely
because SSA countries, including Tanzania, are experi-
encing rising burdens of non-communicable conditions.
Thus, there is a need to examine continuity in medica-
tion use.
Methods
Study setting
The study was conducted in the village of Viwanjasitini
and at the diabetes clinic in the Kilombero district in the
Morogoro region of Tanzania. Viwanjasitini, a semi urban
A
Services provided
Level of health services delivery
Referral and specialized hospital
Regional hospital
Health center
Dispensary level
Health post
District hospital
B – Diabetes services are not provided
Key: A - Diabetes services are provided
B
Figure 1 Structure of the Public health service delivery in Tanzania.
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The village had a total of 12,823 inhabitants (6,359 men
and 6,464 women). The village was included in the study
in order to gain access to people living in the community
who were diagnosed with diabetes.
The only diabetes clinic in the district, situated on the
premises of the designated district referral hospital, is less
than five kilometers away from the village. The clinic pro-
vides diabetes services to residents of the district and of the
neighboring areas. The clinic does not provide medications,
but instructs patients to buy them from the hospital phar-
macy. The costs of the medications are covered by the pa-
tients themselves or by health insurance, which is generally
available to government employees only. The diabetes clinic
is staffed by three clinicians (a consultant physician, and
two assistant medical officers), a nurse assistant, a nursing
officer, and two medical attendants. At the time of the
study, more than 497 diabetes patients were registered atTable 1 The 5As access to care dimensions
Dimensions of
access
Description
Acceptability The relationship between clients’
attitudes about the service characteristics
Affordability The relationship between the price
of the services and the clients’ ability to pay
Accessibility The relationship between the location of the service
and the location of the clients taking into account
client transportation resources, travel time, distance,
and cost
Availability The relationship between the amount and the type
of the existing health services and the clients’ needs
Accommodation The relationship between the manner in which the
services are organized and clients’ expectations
Source: Penchnasky and Thomas 1981.the clinic and were scheduled for routine monthly visits for
the monitoring of their condition and the refilling of their
diabetes medications. The clinic was included in the study
in order to gain access to people who were living in remote
villages. This study was part of a bigger qualitative study on
health care-seeking behavior among patients with diabetes
or malaria. In this paper, we present results from the inter-
views on diabetes, as we are interested in exploring the
lived experiences of individuals.
Study design and recruitment of participants
A qualitative research design employing in-depth inter-
views was chosen in order to collect information on per-
sonal experiences related to the continuity of diabetes
medication use. The interviews were conducted by a
team of three social scientists, including the first author
and two trained research assistants. The study partici-
pants were adults who had been diagnosed with diabetes
more than six months prior to the time of the study.
The participants from the semi-urban village were pur-
posively selected with the help of the village leaders. The
researchers visited household in the village, asking
whether anyone in the household had diabetes. To avoid
recruiting people of the same social network, different
entry points were used. If an individual reported that he
or she had a diabetes diagnosis, his or her clinic or med-
ical card was reviewed for confirmation. Participants
from the remote villages were selected from among the
clinic attendees with the help of a clinic nurse. During a
visit to the clinic, the researcher—in consultation with
the clinic nurse—purposively identified individuals who
came from rural areas, after the patients were registered
and their blood pressure and weight were measured.
The participants recruited through the clinic were paid a
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costs. The recruitment of participants at both sites
ended after data saturation was reached.
Data collection and analysis
Data collection was conducted between February and
March 2013. In-depth interviews were conducted in Swahili
with 19 adult diabetes patients. Of these patients, nine were
male and 10 were female. The in-depth interview guides,
which were refined following the analysis of the pilot study,
were applied during the interviews. The interviews were
45–60 minutes long. The transcripts were anonymized and
crosschecked for quality by the first author before they
were imported to NVivo 9 (QSR International Pty Ltd,
Australia). All of the transcripts were analyzed in their ori-
ginal language. The analysis process had two levels. The first
level involved developing inductive and deductive codes.
The second level involved categorizing the codes into
themes and family codes following principles of grounded
theory. After linking the emerging concepts and the 5As ac-
cess to care dimensions, the following themes emerged: (i)
perceptions of the chronicity of diabetes and of the accept-
ability of medications, (ii) affordability, (iii) accessibility, and
(iv) availability and accommodation.
Ethical approval
The study was approved by institutional review boards of
the Faculty of Spatial Sciences, University of Groningen in
the Netherlands; the Ifakara Health Institute (IHI) in
Tanzania; and the National Tanzanian Medical Research
Co-coordinating Committee of the National Institute for
Medical Research (NIMR). Each participating individual
provided a verbal consent to participate.
Results
Perceptions of the chronicity of diabetes and of the
acceptability of medications
The participants demonstrated that they understand that
diabetes is a chronic disease, with several stating that
diabetes is not a curable disease, but a lifelong condition:
“…Diabetes is not a curable disease. Rather, the
medicines we are using are just for relief; that is what
we were told at the clinic one day.” Female 03,
58 yearsa
As they were aware of the chronicity of diabetes, partici-
pants expressed despair and hopelessness about regaining
their level of health prior to the onset of diabetes:
“….These medications are not a cure… they only reduce
the severity of the disease so that one can continue
living… being cured from this disease is a dream that
will never be realized.” Female 13, 40 yearsMost participants nonetheless had positive views of
diabetes medications, citing their benefits:
“…I mean when you are taking the medications you
don’t feel a difference…. you feel normal…. eeh I mean
for those of us with diabetes it is the medicine that
keeps us alive …if you use your medicine as
instructed.... you will have energy and may perform
your activities as usual.. no one will know what you
are suffering from…” Male 04, 52 years
In addition to having a positive opinion of diabetes med-
icines, some participants reported using local herbs, such
as Moringa oliferus, aloe vera, lime leaves, and herbal mix-
tures. Information from relatives/colleagues and/or adver-
tisements from local herbalists on the effectiveness of
herbal treatments in managing the condition were cited as
motivations for using them. Other participants expressed
doubts about the long-term use of the diabetes medica-
tions, and some noted that taking the medicines while
drunk and/or on an empty stomach can have negative ef-
fects. Forgetting to take medicines when the condition is
less severe has been shown to contribute to interrupted
use. Overall, the study participants acknowledged that tak-
ing their diabetes medications continuously is the best
way to manage their condition. Among the main reasons
participants gave for taking their medications as pre-
scribed was the reduced severity of their symptoms, such
as frequent urination, fever, and fatigue. While the partici-
pants accepted the medicines and were willing to use
them, lack of access remained a barrier to continuous use.
Affordability
Several participants said they were unable to afford their
consultation, laboratory, and medication costs. On aver-
age, diabetes patients reported monthly costs of Tshs
5,000 (USD 3.2) for consultation and laboratory tests,
and of Tshs 4,600 – Tsh 52,000 (USD 2.9 – 33.7) for
medicines, depending on whether they were using oral
hypoglycemic medications or insulin. The minimum
monthly wage of a public employee in Tanzania is Tshs
265,000 (USD 171.521). However, based on estimates of
monthly expenditures made by researchers working in
the field, the average monthly income per person in the
district is Tshs 14,946 (UDS 9.6). Having to rely on
erratic sources of income, such as income from subsist-
ence farming, made paying for the medications espe-
cially difficult:
“….Most of us are jobless; we depend on farming to
earn a living. We use the hand hoe and depend on
whether it rains or not. If it rains you are thankful
because you can harvest something to sell and get
enough money for even a half dose. If it does not rain
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Female 15, 36 years
Under the cost-sharing policy in Tanzania, individuals
with chronic diseases like diabetes are exempted from pay-
ing for medical treatments at public health facilities. How-
ever, because of the poor quality of public services—and
because public services are unavailable in most areas of the
country—these individuals had to use private health ser-
vices, and thus had to cover the costs themselves or to go
without medications.
People who lived in remote villages reported finding
the high cost of medications and related services espe-
cially challenging. When they needed to refill their pre-
scription, they had to cover not only the consultation
and laboratory costs, but also the costs of transport,
lodging, and food:
“I need to have enough money for a return transport,
accommodation, and food before I can think about
going to the clinic—and that doesn’t include the
money for laboratory tests and medicines… my
financial resources are low…. I just leave it to God—if
I have money I go to get the medicines, and if I don’t, I
stay home and go without….” Female 06, 41 years
The participants reported using several strategies for
getting the money they needed to adhere to their medi-
cation regimen. To pay for diabetes services, some par-
ticipants said they spent less money on family needs,
such as sending children to school. In some cases,
people had to sell assets, which then pushed them and
their families further into poverty:
“….Because …you need medicines…. you have to sell
whatever you have in the household to meet medical-
related costs ….and in most cases the money you get…
buys some medicine ….but only enough for a certain
amount of time. Then do you think it will be easy to
replace what you sold? …What will you do after you
sell everything? …With this disease you need enough
money to pay for medicine until the day you go to the
grave.” Male 08, 57 years
To avoid the costs associated with clinical consult-
ation and laboratory tests, some participants reported
buying medications directly from pharmacies. To obtain
medications from a pharmacy, patients presented their
prescription book, which contains the relevant medical
and drug histories.
A number of participants also reported asking family
members for financial support, including husbands, wives,
and children; while some reported borrowing cash from
friends. In addition, some participants said they decidewhether they need to take their medication, or whether
they can skip it, based on a self-evaluation of their
condition:
“…We are supposed to use these medicines every day,
but when I look at the real situation…. I wonder
where the money for buying enough medicine to use
every day would come from. If I feel a little better on a
certain day I keep the medicine so that I can use it on
another day.” Male 11, 73 years
Participants reported using less than the recom-
mended dosage to delay having to refill a prescription:
“…Medicines are very important for treating this
disease…That is why you find people using a half of
the dose and saving the rest for the days ahead,
because you do not know how it is going to be
tomorrow… [Have you experienced that situation?]
Yes…sometimes instead of injecting myself twice in a
day I inject myself only once… At least when I do this
the medicine for a month can last me two months.”
Male10, 75 years
Some participants said they went without medications
when they could not afford them. Others reported sharing
their diabetic medicines with other diabetes patients in
the neighborhood when one of them ran out. This type of
sharing appears to reduce the risk that an individual will
miss a dose.
Accessibility
Inadequate access to diabetes medications and services
appears to have negatively affected medication use and
the continuity of use among the participants, especially
among those living in remote villages. Residents of the
district have access to diabetes services at the district
diabetes clinic of the district referral hospital (see
Figure 1), located in Ifakara town. Thus, the participants
who were living in remote villages reported having to
travel to town to access the services. Lack of a reliable
means of transport, long waiting and journey times, and
high transport costs affected access to care. To save on
transportation and related costs, some participants ad-
mitted giving their diabetes book and money to buy
medications to people who were going to town. Travel
time and costs were reported to double during the rainy
season, a period when some people were unable to ac-
cess care of any kind:
“….During the rains it is very difficult to come to the
clinic because our roads are impassable, and cars are
unable to reach the village….. This is why even I could
not come to the clinic last month…” Male 09, 58 years
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The availability of diabetes services, including medicines,
was cited as another barrier to continuous use. Although
lack of money appeared to be the main barrier to acces-
sing these medicines, the participants also mentioned that
the medicines were not always available at lower-level
health facilities (see Figure 1), and that the supply of medi-
cations at the district diabetes clinic was unreliable:
“…The problem comes when you need medicines but
you cannot find them… If you are in the village and
run out… you cannot get them there....You must come
here [town] to collect them….” Female 07, 54 years
“…For instance, last year diabetes medications
disappeared for almost three weeks ….I could not find
them anywhere in Ifakara ….and during that time I
didn’t have a single medicine from the hospital….
That it is when you find us in these other places (local
healers/herbalists).” Male 18, 56 years
In addition, participants expressed concerns about the
structure and organization of diabetes services in the dis-
trict. For example, participants reported that patients are
advised to fast in preparation for fasting glucose measures,
and to arrive at the clinic early for the tests. However, after
reaching the facility, they often found that their consult-
ation with the diabetes specialist was delayed as doctors
made morning rounds in the wards before going to the dia-
betes clinic. Thus, participants reported having to wait six
to eight hours for their consultation and prescription refill
before eating. The inconvenience and discomfort associated
with having to wait so long while hungry to access the ser-
vices therefore appear to contribute to interruptions in
medication use.
Discussion
Our goal in this study was to explore lived experiences
with diabetes medication use among adults living in
rural areas. The participants were found to have positive
perceptions of medications based on their efficacy, and
to be aware that they need to take these medicines regu-
larly. Thus, access to diabetes medications was shown to
be the main barrier to use. The insufficient availability of
diabetes medications [13,14] and their high costs [2,25]
continue to make diabetes management in SSA, and in
Tanzania in particular, [6,32,33], challenging. In the
study area, diabetes medications often were not avail-
able, accessible, or affordable; especially for rural resi-
dents served by the primary health care facilities. There
is a strong need to realign the health care services so
that they cater to diabetes patients, as well as to those
seeking episodic care.The inclusion of some of the diabetes medicines in the
national essential medicine list (NEMLIT) for Tanzania
[34] is an indication that the government recognizes that
these medicines are needed at primary-level facilities,
and would be willing to improve the availability and the
accessibility of diabetes medications. However, the inclu-
sion of these medicines in the NEMLIT has so far not
translated into improvements in drug supplies in health
care facilities. This failure to ensure that facilities have
adequate supplies of diabetes medicines forces many pa-
tients to access the medicines through the private sector,
which imposes very heavy cost burdens on the patients
and their families. To improve the availability and the
accessibility of the diabetes medicines in the community,
the government should take action to ensure the effect-
ive implementation of the NEMLIT.
Consistent adherence with the prescribed medication
regimen is one of the critical factors in glycemic control
[15,28] and the prevention of further clinical symptoms.
In this study, participants reported that the high cost of
clinical services and medications was the main reason
why they sometimes failed to take their medications as
prescribed. To delay having to refill their prescriptions,
participants admitted they sometimes took a smaller
dose than recommended or skipped a dose altogether. A
similar pattern of failing to adhere to a medication regi-
men due to cost has also been observed among hyper-
tension patients in other SSA countries [35,36]. The lack
of adherence with medical recommendations may in-
crease the risk of developing chronic complications [15].
Reductions of medication prices by pharmaceuticals
could help to improve diabetes medication use and con-
tinuity. In addition, there is a need for ongoing health
education campaigns which alert people with chronic,
non-communicable conditions to the importance of tak-
ing their medications as recommended.
In line with observations made in other African settings
[37,38], the study participants reported selling family as-
sets to cover their medication costs. But in order to sell
assets, a household has to have saleable property and ac-
cess to potential buyers. The sale of assets to cover med-
ical bills has been associated with the depletion of a
household’s physical resources, and thus with an increased
risk that the family will fall into poverty [24]. In turn, the
consequences of poverty might even be greater for people
with chronic conditions such as diabetes, who have add-
itional expenses associated with long-term medication
use. Ensuring that people have access to the health care
services they need, and providing them with protection
from financial risks, are steps toward ensuring universal
health care coverage [39]. The current community health
insurance schemes in Tanzania which aim to reduce direct
out-of-pocket payments have so far mainly served people
with episodic illnesses [40]. These schemes need to be
Metta et al. BMC Health Services Research  (2015) 15:111 Page 7 of 8strengthened to accommodate access to NCD health ser-
vices, including access to medication. Other strategies
based on social protection mechanisms—such as public
subsidies for free care of the kind provided to patients
with HIV/AIDS—could help to protect people with non-
communicable diseases from financial risks, and encour-
age medication use and continuity of use.
Having social support from friends and family was shown
to contribute to the resilience of the participants and to the
likelihood that they were taking their medications as pre-
scribed. These kinds of support with diabetes management
appear to be associated with increased patient self-efficacy,
medication regimen adherence, and better health outcomes
[41,42]. It is therefore crucial to involve and educate house-
hold members in the management of diabetes care.
This study provides very important findings on experi-
ences related to diabetes medication use and continuity of
use from the perspectives of people living in rural areas
where access to medications is limited. Recruiting study
participants from the diabetes clinic allowed us to gain
wider perspectives on experiences with continuous medi-
cation use from people in different rural areas. Although
the study involved a particular group of people, it is likely
that similar patterns of continuous medication use experi-
ences exist in other rural parts of Tanzania and elsewhere
in SSA, as inadequate availability of diabetes services and
out-of-pocket payments are features of many SSA health
systems [2,13,14]. The study findings can provide useful
insights for developing strategies to improve and support
access to diabetes care and treatments, to enhance self-
management activities, and to encourage appropriate use
and continuity of use of medications among patients.
Conclusion
The study found that perceptions of diabetes medica-
tions were positive, but that the cost of the medications
was a major barrier to their consistent use. Among the
strategies the participants reported using to raise money
to pay for diabetes medications were spending less
money on family needs and selling household assets. A
number of participants also reported sourcing their
medicines from pharmacies to save on consultation and
laboratory costs, asking family and friends for financial
support, and borrowing cash. In addition, some partici-
pants admitted using less than the recommended dos-
age or skipping doses, and sharing medicines with other
diabetes patients. However, these coping strategies may
prove ineffective, and could compromise the health of
the patient. More comprehensive strategies are there-
fore needed to encourage consistent medication use
among people with chronic conditions. These strategies
could include the reduction of prices by pharmaceuti-
cals, the strengthening of community risk-pooling
mechanisms (such as the introduction of a national or asocial health insurance program, or of community
health funds), and sustained health campaigns aimed at
patients and the community.
Endnote
aAs all of the quotes have been translated from Swahili
to English, they may not follow a strict grammatical route.
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